Research review
DIM (diindolylmethane): what the research does and doesn't show
No human trial of DIM specifically tracked weight gain, headaches, diarrhea, bloating or constipation as an outcome. The tolerability data that exists found mild nausea in a small share of one trial's participants; three published case reports separately describe rare, more serious reactions.
DIM's research base doesn't answer several of the questions people search for most: no trial we reviewed specifically tracked weight gain, headaches, diarrhea, bloating, or constipation as an outcome. Here's what the human trials that exist actually measured for tolerability, and where the gaps are.
What the evidence doesn't support
It doesn't support or rule out a link between DIM and weight gain, headaches, diarrhea, bloating, or constipation — none of the human trials we reviewed specifically tracked those symptoms as outcomes. It doesn't support DIM as tested for use in fertility treatment or during pregnancy: none of the human trials enrolled pregnant women, and the fertility-related marketing around DIM isn't backed by a trial that tested it for that purpose. It also doesn't support the idea that DIM is broadly, mildly tolerated the way a vitamin is — the documented safety picture includes a small number of serious, rare case reports alongside the tolerability data below.
What the trials found
The trial most directly designed to measure DIM's tolerability was a 2021 pharmacokinetics study in 7 healthy adults, taking about 90.6 mg/day of an absorption-enhanced formulation for a week, with blood and urine tracked for 48 hours after the last dose. That study measured metabolite levels, not side effects, and didn't report on adverse events one way or the other (PMID 34035125). A separate trial that did track tolerability — 64 women with cervical cell changes, taking about 2 mg/kg/day of DIM for 12 weeks — reported mild nausea in 3% of the DIM group and no organ toxicity on bloodwork, but didn't break out weight, headache, or digestive symptoms individually (PMID 19939441). A year-long trial in 130 women taking DIM alongside tamoxifen reported "minimal" adverse events that didn't differ between the DIM and placebo groups, without listing specific symptoms (PMID 28560655).
Separately from tolerability data, three published case reports document rare, serious reactions attributed to DIM supplements: an ischemic stroke in an otherwise healthy 38-year-old woman with an undiagnosed heart defect (PMID 36448494), a serious systemic allergic-type reaction called DRESS syndrome (PMID 26298826), and a retinal condition with headaches and blurred vision following two months of excessive daily use, which resolved within 8 weeks of stopping (PMID 25423641). None of these three reports describe weight gain, ordinary headaches, diarrhea, bloating, or constipation — they're a different, more serious category of reported harm, and they're rare, individually documented cases rather than a measured rate.
Questions people ask
Can DIM supplement cause weight gain?
No trial we reviewed measured weight change as an outcome of taking DIM. One trial's secondary finding was actually a greater drop in body-fat percentage in the DIM group versus placebo, though the study's own authors flagged that as preliminary, not a confirmed effect — see what does DIM do for women? for that trial's full context. There's no trial evidence that DIM causes weight gain.
Can DIM supplement cause headaches?
No trial we reviewed specifically tracked headaches as a side effect of typical DIM doses. One published case report describes headaches as part of a serious retinal condition following two months of excessive daily use — a different situation from ordinary dosing, and a single documented case, not a measured rate.
Can DIM supplement cause diarrhea, bloating, or constipation?
None of the trials we reviewed tracked these symptoms individually. The tolerability data that does exist found mild nausea in a small percentage of one trial's participants and no clinically significant bloodwork changes in another, without breaking out digestive symptoms specifically.
When to talk to a doctor
DIM is not a treatment for weight, headaches, or digestive symptoms, and nothing here is a substitute for medical guidance if a symptom is new or persistent. Stop taking it and see a doctor if you develop unusual or unexplained symptoms — the published case reports above describe rare but serious reactions, including neurological and visual symptoms. If you're pregnant or nursing, ask a doctor before taking any supplement.
Related reading: DIM side effects, DIM benefits: what the research does and doesn't show, and who should not take DIM?
Sources
- 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans A 2021 pharmacokinetics study in 7 healthy adults taking about 90.6 mg of DIM a day (two capsules of an absorption-enhanced formulation) for a week found the body extensively metabolizes DIM into several other compounds detectable in plasma and urine — more processing than earlier studies had found, which reported only unchanged DIM.
- Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia A randomized trial of 64 women with moderate-to-severe cervical cell changes, comparing oral DIM (about 2 mg/kg/day) with placebo for 12 weeks, found DIM well tolerated (mild nausea in 3% of the DIM group, no organ toxicity) but no statistically significant difference from placebo on any outcome measured, despite a high rate of improvement in both groups.
- A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen A year-long, placebo-controlled trial of 130 women taking tamoxifen found that adding 300 mg/day of DIM changed estrogen-metabolite ratios favorably but also reduced blood levels of tamoxifen's own active metabolites, including endoxifen — a finding the study authors flagged as a reason to determine whether it could reduce tamoxifen's effectiveness, not evidence that combining them is beneficial.
- The Serious Side of Supplements: An Ischemic Stroke in a Healthy 38-year-old Female A published case report describes an ischemic stroke in an otherwise healthy 38-year-old woman with an undiagnosed heart defect (a patent foramen ovale) who was taking a DIM supplement; the authors present it as a reminder to consider supplement use as a rare contributing factor in unexplained stroke, not as proof that DIM alone caused it.
- Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane A published case report, titled to describe exactly this, documents a serious systemic allergic-type reaction (DRESS syndrome) attributed to a DIM supplement.
- Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane A published case report describes a woman who developed a serious retinal condition with headaches and blurred vision after two months of excessive daily DIM use; her vision returned to baseline within 8 weeks of stopping.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.